| High-dose vitamin C enhances cancer immunotherapy A Magrì, G Germano, A Lorenzato, S Lamba, R Chilà, M Montone, ... Science translational medicine 12 (532), eaay8707, 2020 | 191 | 2020 |
| Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo L Carrassa, R Chilà, M Lupi, F Ricci, C Celenza, M Mazzoletti, M Broggini, ... Cell Cycle 11 (13), 2507-2517, 2012 | 130 | 2012 |
| Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma R Chilà, A Basana, M Lupi, F Guffanti, E Gaudio, A Rinaldi, L Cascione, ... Oncotarget 6 (5), 3394, 2015 | 73 | 2015 |
| Role and therapeutic potential of CDK12 in human cancers R Chilà, F Guffanti, G Damia Cancer treatment reviews 50, 83-88, 2016 | 58 | 2016 |
| CD4 T cell–dependent rejection of beta-2 microglobulin null mismatch repair–deficient tumors G Germano, S Lu, G Rospo, S Lamba, B Rousseau, S Fanelli, D Stenech, ... Cancer discovery 11 (7), 1844-1859, 2021 | 48 | 2021 |
| Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts F Ricci, L Brunelli, R Affatato, R Chilà, M Verza, S Indraccolo, F Falcetta, ... Therapeutic advances in medical oncology 11, 1758835919839543, 2019 | 46 | 2019 |
| DNA damage response inhibitor combinations exert synergistic antitumor activity in aggressive B-cell lymphomas V Restelli, M Lupi, R Chilà, M Vagni, C Tarantelli, F Spriano, E Gaudio, ... Molecular cancer therapeutics 18 (7), 1255-1264, 2019 | 41 | 2019 |
| Identification of PLK1 as a new therapeutic target in mucinous ovarian carcinoma R Affatato, L Carrassa, R Chilà, M Lupi, V Restelli, G Damia Cancers 12 (3), 672, 2020 | 30 | 2020 |
| Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines SFV Oliveira, M Ganzinelli, R Chilà, L Serino, ME Maciel, CA Urban, ... PloS one 11 (1), e0145647, 2016 | 29 | 2016 |
| In vitro and in vivo activity of lucitanib in FGFR1/2 amplified or mutated cancer models F Guffanti, R Chilà, E Bello, M Zucchetti, M Zangarini, L Ceriani, M Ferrari, ... Neoplasia 19 (1), 35-42, 2017 | 28 | 2017 |
| Chk1-Mad2 interaction: a crosslink between the DNA damage checkpoint and the mitotic spindle checkpoint R Chilà, C Celenza, M Lupi, G Damia, L Carrassa Cell Cycle 12 (7), 1083-1090, 2013 | 25 | 2013 |
| Targeting the DNA damage response pathways and replication stress in colorectal cancer E Durinikova, NM Reilly, K Buzo, E Mariella, R Chilà, A Lorenzato, ... Clinical Cancer Research 28 (17), 3874-3889, 2022 | 23 | 2022 |
| Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736 V Restelli, R Chilà, M Lupi, A Rinaldi, I Kwee, F Bertoni, G Damia, ... Oncotarget 6 (35), 37229, 2015 | 23 | 2015 |
| Combination of the c-Met inhibitor tivantinib and zoledronic acid prevents tumor bone engraftment and inhibits progression of established bone metastases in a breast xenograft … S Previdi, F Scolari, R Chilà, F Ricci, G Abbadessa, M Broggini PloS one 8 (11), e79101, 2013 | 19 | 2013 |
| Platinum sensitivity and DNA repair in a recently established panel of patient-derived ovarian carcinoma xenografts F Guffanti, M Fratelli, M Ganzinelli, M Bolis, F Ricci, F Bizzaro, R Chilà, ... Oncotarget 9 (37), 24707, 2018 | 17 | 2018 |
| Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance V Amodio, S Lamba, R Chilà, CM Cattaneo, B Mussolin, G Corti, G Rospo, ... Cancer Cell 41 (1), 196-209. e5, 2023 | 16 | 2023 |
| Multi-chemotherapeutic schedules containing the pan-FGFR inhibitor ARQ 087 are safe and show antitumor activity in different xenograft models R Chilà, T Hall, G Abbadessa, M Broggini, G Damia Translational Oncology 10 (2), 153-157, 2017 | 8 | 2017 |
| Mitochondrial structural alterations in ovarian cancer patient-derived xenografts resistant to cisplatin F Ricci, A Corbelli, R Affatato, R Chilà, M Chiappa, L Brunelli, R Fruscio, ... American Journal of Cancer Research 11 (5), 2303, 2021 | 7 | 2021 |
| Combining ibrutinib with Chk1 inhibitors synergistically targets mantle cell lymphoma cell lines V Restelli, M Lupi, M Vagni, R Chilà, F Bertoni, G Damia, L Carrassa Targeted oncology 13, 235-245, 2018 | 7 | 2018 |
| Urban Cde A, et al. Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines SF De Oliveira, M Ganzinelli, R Chilà, L Serino, ME Maciel PloS one 11, e0145647, 2016 | 7 | 2016 |
